Gadoquatrane全球市場規模、佔有率、成長分析、按應用、按最終用戶 - 產業預測，2024-2031 年

Global Gadoquatrane Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

出版日期: 2024年04月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球Gadoquatrane市場規模為18.4億美元，預測期間（2024-2031年）年複合成長率為5.28%，從2023年的19.4億美元增至2031年的29億美元，預計將成長至20美元百萬。

磁振造影（MRI）顯影劑用於提高 MRI 檢查期間獲得的影像品質。這些藥物改變了被掃描組織的磁性，可以區分健康組織和患病組織。四聚Gadoquatrane是一種用於磁振造影的新型高效 mGBCA。 Gadoquatrane具有理想的理化特性（高弛豫性和穩定性、低蛋白結合）和與常見市售 mGBCA 相似的 PK 特性（快速細胞外分佈、完整條件下腎介導的活性）。由於癌症、神經系統疾病和心血管疾病等慢性疾病需要診斷影像來進行診斷和治療計劃，因此未來幾年對 MRI顯影劑的需求可能會顯著增加。此外，人口老化和對非侵入性診斷治療的需求不斷成長預計將支持市場擴張。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2023年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Bayer AG

簡介目錄

Product Code: SQMIG35I2135

Global Gadoquatrane Market was valued at USD 1.84 Billion in 2022 and is poised to grow from USD 1.94 Billion in 2023 to USD 2.92 Billion by 2031, at a CAGR of 5.28% during the forecast period (2024-2031).

Contrast media agents for magnetic resonance imaging (MRI) are used to improve the quality of pictures obtained during an MRI scan. These medications alter the magnetic properties of the tissue being scanned, allowing for the distinction between healthy and ill tissues. Tetrameric gadoquatrane is a novel, highly effective mGBCA for use in magnetic resonance imaging. Desirable physicochemical properties (high relaxivity and stability, low protein binding) and a nearly identical PK profile to popular mGBCAs on the market (rapid extracellular distribution, quick excretion via the kidneys in an intact state) are displayed by gadoquatrane. In the upcoming years, there will likely be a large increase in the need for MRI contrast media agents due to the rising frequency of chronic illnesses like cancer, neurological disorders, and cardiovascular diseases, all of which need imaging for diagnosis and treatment planning. Further propelling the market expansion are anticipated to be the aging population and the rising need for non-invasive diagnostic treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gadoquatrane Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gadoquatrane Market Segmental Analysis

Global Gadoquatrane Market is segmented based on Applications, End User, and region. Based on End User, the market is segmented into Hospital, Imaging Centers. Based on region the global Gadoquatrane Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Gadoquatrane Market

Chronic diseases like cancer, cardiovascular disease, and neurological problems are becoming more common, which is driving up the need for MRI scans for diagnosis and treatment planning. Contrast chemicals are used to increase the quality of these images and make it easier for medical professionals to identify irregularities. Additionally, as the global population ages, older people are more likely to have chronic illnesses, necessitating more regular diagnostic imaging. Consequently, there is a rise in the need for contrast agents and MRI scans. Furthermore, there is no need for surgery or other intrusive procedures because MRI is a non-invasive diagnostic method. The market is expanding due to the growing demand for MRI scans and contrast media agents as more patients look for non-invasive diagnostic options. Furthermore, advances in MRI technology have made it possible to produce higher-quality pictures, which can be enhanced even further with the addition of contrast media agents. As a result, there is now a greater need for these medications in both clinical and research settings. Additionally, greater funding is being allocated by governments and private healthcare institutions to the infrastructure of the healthcare sector, which includes advanced imaging technologies like magnetic resonance imaging (MRI). The increased accessibility of MRI scans and contrast media for patients is driving up demand for these products.

Restraints in the Global Gadoquatrane Market

MRI contrast media agents may become less expensive due to a variety of factors that limit demand. Among these reasons include cost, safety issues, the advent of alternative diagnostic methods, and the shift to value-based treatment. Furthermore, the development of non-contrast MRI methods might make market growth more difficult. As a result of technological developments, less contrast agents are needed for non-contrast MRI treatments, which are becoming more accurate and efficient. Furthermore, as MRI contrast agents can be costly, some patients and medical professionals may decide to forego contrast in favor of non-contrast MRI techniques in order to save money in light of the growing cost of healthcare. Additionally, there have been a few reported cases of unfavorable side effects, such as allergic responses and nephrogenic systemic fibrosis (NSF), even though MRI contrast agents are generally thought to be harmless. As awareness of these risks grows, some people and medical professionals may choose to completely avoid using contrast agents. Furthermore, value-based care-which emphasizes delivering high-quality treatment while reducing costs-is being emphasized by healthcare providers more and more. This could lead to a decreased need for pricey contrast agents. Additionally, there are situations where ultrasonography or CT scans can be used instead of MRIs, which further minimizes the requirement for MRI contrast agents.

Market Trends of the Global Gadoquatrane Market

Contrast drugs based on gadolinium have been associated with uncommon but dangerous side effects, especially in those with kidney disease. Consequently, there's been a growing interest in creating gadolinium-free contrast agents, like manganese-based agents and iron oxide nanoparticles.

The goal of research is to create contrast agents that can target particular bodily tissues or cells. This may make it possible to obtain more accurate imaging and provide better illness diagnosis and therapy.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact